Evaluation on the Safety of Ticagrelor among Chinese ACS Patients

Trial Identifier: D5130R00026
Sponsor: AstraZeneca
NCTID:: NCT02430493
Start Date: May 2015
Primary Completion Date: March 2017
Study Completion Date: March 2017
Condition: Coronary Artery Disease

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
China Beijing, China
China Changchun, China
China Changsha, China
China Dalian, China
China Guangzhou, China
China Huai'an, China
China Jinan, China
China Nanjing, China
China Shanghai, China
China Shenzhen, China
China Suqian, China
China Tai'an, China
China Wuhan, China
China Xuzhou, China
China Zhengzhou, China